HARNESSING ARTIFICIAL INTELLIGENCE IN TRANSLATIONAL RESEARCH: REVOLUTIONIZING DIAGNOSTICS AND TREATMENT

Abstract

Artificial Intelligence (AI) is transforming face of translational research by providing possibility of speedy yet effective choice of decisions in both the diagnostic and therapeutic fields.  Its integration into the healthcare system has contributed to the transition to a proactive, data-based therapy, at least in such domains as diagnostics, personalized medicine, and therapy optimization.This paper examines the manner in which AI has the potential to enhance the translation process through the use of a multimodal structure that usually incorporates both deep learning and machine learning models.  We applied clinical data such as imaging, genetic sequencing, and electronic health records to supervised learning algorithms such as CNN, SVM, and XGBoost.  The approach is devoted to transparency and interpretability based on predictive modeling, cross-validation, and SHAP.All the experiments revealed that AI models exhibited an excellent classification performance (mean classification accuracy = 96.2%), where F1-scores were above 0.94 across different clinical applications, including diagnostic imaging, locating genomic mutations, and predicting pharmacogenomic responses.  Moreover, in terms of individualized treatment prescriptions, AI models showed higher accuracy rates compared to the regular protocol in predicting positive outcomes of the patients.  The models were also effective even in datasets collected in multiple institutions demonstrating that they were powerful and could be applied in real-life scenarios.These findings depict that AI not only assists in the earlier detection of the problem and better prediction of outcomes but also makes treatment more precise.  Nonetheless, issues of ethics, such as data privacy, algorithmic and model explainability and fairness remain highly significant to its appropriate use.  The research summarizes implications that could be applied to the estimulation that AI can transform translational medicine but only through collaborating, rigorous testing, and equitable implementation into clinical practice.